Interface, Inc.
Interface, Inc. Q3 FY2025 earnings call
October 31, 2025 · fiscal period ended 2025-09
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2025-10-31
Management highlights
- Interface had strong Q3 with currency-neutral net sales growth of 4% and profitability gains. - One Interface strategy is driving results, with unified selling teams in U.S. since Jan 2024 driving growth. - Nora Rubber grew 20% in Q3 and 19% YTD, with investments in automation, productivity, and innovation planned. - Introduced stellar Horizon's carpet tile collection and new resilient products. - Healthcare billings up 29%, corporate office up 5% Q3 and YTD, education billings slight Q3 decline but YTD up high single digits. - Recognized with awards for sustainability.
Segment performance
Interface delivered currency-neutral net sales growth of 4%. Americas saw currency-neutral net sales increase 4%, and EAAA also had 4% growth. Nora Rubber grew 20% in the third quarter and 19% year-to-date. Global healthcare billings were up 29% with double-digit gains in Americas and EAAA. Corporate office billings were up 5% in Q3 and YTD. Education billings declined slightly in Q3 but remained up high single digits YTD. Net sales increased through a balanced mix of price and volume, adjusted gross profit margin expanded by 208 basis points.
Guidance
- Raised full-year 2025 guidance: net sales $1.375B - $1.390B, adjusted gross profit margin 38.5% of net sales, adjusted SG&A expenses $362M, adjusted interest and other expenses $25M, adjusted effective income tax rate 26%, capital expenditures $45M, fully diluted weighted average share count 59.1 million shares. - Anticipate similar tariff-related gross profit percentage dilution in Q4 as in Q3.
Risks
- Tariff-related costs diluting gross profit percentage, with approximately 30 basis points diluted in Q3 and anticipated 50 basis points in Q4. - Dynamic market environment posing challenges to maintaining margins and driving growth.
Q&A highlights
Q: Expansion of addressable market and selling full portfolio?
A: Added global product category management to drive innovation funnel. Selling full suite of products to global customers, still in early days but continuing to build out.
Q: Capital allocation for CapEx next year?
A: Large portion related to Nora, but also innovation and automation investments outside of Nora.
Q: Stock buyback program?
A: Opportunistic, keeping in mind #1 priority of investing in business for growth, margin expansion, and innovation, while returning capital to shareholders when opportunity arises.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | $0.61 | $0.46 | +32.6% | $0.48 |
| Revenue | $364.5M | $349.6M | +4.3% | $344.3M |
Transcript
October 31, 2025Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.